Induction of Immune-mediated aBscOpal Effect thrOugh STEreotactic Radiation Therapy in Metastatic Melanoma Patients Treated by PD-1 + CTLA-4 Inhibitors (BOOSTER MELANOMA)
Clinical trial NCT03354962 · TERMINATED
Trial details
- NCT number
- NCT03354962
- Sponsor
- Institut Claudius Regaud
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-15
- Primary completion
- 2020-02-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.